Thrivent Financial for Lutherans
KRYS icon

Thrivent Financial for Lutherans’s Krystal Biotech KRYS Stock Holding History

Thrivent Financial for Lutherans’s Portfolio KRYS Stock Details KRYS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.45M Sell
17,226
-508
-3% -$135K 0.01% 960
2025
Q4 		$4.37M Sell
17,734
-850
-5% -$179K 0.01% 1008
2025
Q3 		$3.28M Sell
18,584
-116
-0.6% -$17.4K 0.01% 1046
2025
Q2 		$2.57M Buy
18,700
+110
+0.6% +$16.2K 0.01% 1187
2025
Q1 		$3.35M Sell
18,590
-973
-5% -$164K 0.01% 992
2024
Q4 		$3.06M Sell
19,563
-291
-1% -$51.6K 0.01% 1160
2024
Q3 		$3.61M Sell
19,854
-771
-4% -$149K 0.01% 1083
2024
Q2 		$3.79M Buy
+20,625
New +$3.46M 0.01% 1014

Other funds holding KRYS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return